Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001958244-25-004512
Filing Date
2025-12-03
Accepted
2025-12-03 17:58:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5323
  Complete submission text file 0001958244-25-004512.txt   6867
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38957 | Film No.: 251547590
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102
Business Address
ROBINS HARLAN S (Reporting) CIK: 0001780851 (see all company filings)

Type: 144